The Enigma Of Beta(2)-Adrenergic Receptor G(I) Signaling In The Heart - The Good, The Bad, And The Ugly
Weizhong Zhu,Xiaokun Zeng,Ming Zheng,Rui-Ping Xiao
DOI: https://doi.org/10.1161/01.RES.0000184615.56822.bd
IF: 23.213
2005-01-01
Circulation Research
Abstract:See related article, pages 566–573 Four decades ago, it was thought that the cardiac β-adrenergic receptor (AR) was β1AR, the vascular/bronchial counterpart was β2AR, and that β2AR was either nonexistent or nonfunctional in myocardium.1 In the heart, stimulation of β1AR leads to PKA-dependent phosphorylation of a set of Ca2+ regulatory proteins, including sarcolemmal L-type Ca2+ channels, sarcoplasmic reticulum (SR) Ca2+-release channels (ryanodine receptors), SR Ca2+-ATPase (SERCA) and its regulator phospholamban (PLB), and some myofilament proteins, resulting in positive inotropic, lusitropic, and chronotropic effects. However, over the past decade, compelling evidence has shown that the β2AR subtype is expressed in the heart and its signaling and functionalities markedly differ from those evoked by the closely related βAR subtype, the β1AR. Unlike β1AR, β2AR couples dually to Gs and Gi proteins; the β2AR-Gi signaling pathway plays a crucial role in cardioprotection against apoptotic death of myocytes in culture and in vivo (the “good”), while attenuating the β2AR-Gs-mediated inotropic response (the “bad”) (Figure).2 Now, in the current issue of Circulation Research , He et al revealed one “ugly” facet of the β2AR-Gi signaling in a canine heart failure model.3 They demonstrated that in the failing heart, activation of β2AR dampens the ability of β1AR, the primary cardiac subtype, to stimulate ICa,L, thus resulting in an overall dysfunction of βAR inotropic response in the failing heart (Figure).3 Specifically, the effect of βAR stimulation with a nonselective agonist, isoproterenol (ISO), on ICa,L is strikingly diminished in cardiomyocytes from canine failing heart, but can be revived by disruption …